Chinese Journal of Experimental Traditional Medical Formulae
Effect of Panax notoginseng Saponins on Inflammatory Factors and Microglia Cell of SAMP8 Mice
Author:
Affiliation:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
    Abstract:

    Objective: To study the effect of Panax notoginseng saponins(PNS) on the inflammatory factors and microglia cell of senescence-accelerated mouse prone 8 (SAMP8) mice. Method: SAMP8 mice were randomly divided into four groups: PNS high-dosage group, PNS low-dosage group,huperzine A group and model control group. The high-dosage group and low-dosage group were treated with 200, 100 mg·kg-1 PNS respectively per day and the huperzine A group was treated with 0.3 mg·kg-1 huperzine A by intragastric administration,per day for 8 consecutive weeks.The serum cytokines of SAMP8 like interleukin(IL)-1β, IL-6, tumor necrosis factor-α(TNF-α), complement 1q(C1q) were measured by ELISA. The morphological changes of microglia cells were observed by light microscopy with HE staining. Result: The level of IL-1β in the high-dose group was lower than that in the model group (P<0.05), and compared to the model group, the content of IL-6 in PNS high, low-dose groups showed significantly different(P<0.05). The level of C1q in the blank group was higher than that in the high-dose group and positive group. HE staining showed that microglia in the hippocampus of the model group was over-activation, and swallowed nerve cells, while the microglia in the treatment groups was not activated. Conclusion: PNS can reduce the inflammatory response in SAMP8 mice.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 05,2012
  • Revised:
  • Adopted:
  • Online: April 12,2013
  • Published:

Address:

Postcode:100700

Phone:010-84076882

E-mail:syfjx_2010@188.com

® 2024 All Rights Reserved

Supported by:Beijing E-Tiller Technology Development Co., Ltd.